Nantahala Capital Management is an investment fund managing more than $983 billion ran by Taki Vasilakis. There are currently 113 companies in Vasilakis’s portfolio. The largest investments include Soleno Therapeutics Inc and Establishment Labs Inc, together worth $480 billion.
As of 13th August 2024, Nantahala Capital Management’s top holding is 6,164,214 shares of Soleno Therapeutics Inc currently worth over $251 billion and making up 12.7% of the portfolio value.
Relative to the number of outstanding shares of Soleno Therapeutics Inc, Nantahala Capital Management owns less than 0.2% of the company.
In addition, the fund holds 5,025,700 shares of Establishment Labs Inc worth $228 billion, whose value grew 16.4% in the past six months.
The third-largest holding is Peloton Interactive Inc worth $73.9 billion and the next is Evolus Inc worth $63.2 billion, with 5,821,698 shares owned.
Currently, Nantahala Capital Management's portfolio is worth at least $983 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Nantahala Capital Management office and employees reside in New Canaan, Connecticut. According to the last 13-F report filed with the SEC, Taki Vasilakis serves as the Chief Compliance Officer at Nantahala Capital Management.
In the most recent 13F filing, Nantahala Capital Management revealed that it had opened a new position in
Bancorp and bought 675,692 shares worth $25.5 billion.
This means they effectively own approximately 0.1% of the company.
Bancorp makes up
22.3%
of the fund's Finance sector allocation and has decreased its share price by approximately 0.1% in the past year.
The investment fund also strengthened its position in Soleno Therapeutics Inc by buying
3,753,835 additional shares.
This makes their stake in Soleno Therapeutics Inc total 6,164,214 shares worth $251 billion.
Soleno Therapeutics Inc dropped approximately 0.1% in the past year.
On the other hand, there are companies that Nantahala Capital Management is getting rid of from its portfolio.
Nantahala Capital Management closed its position in Lyra Therapeutics on 20th August 2024.
It sold the previously owned 2,820,982 shares for $17.5 billion.
Taki Vasilakis also disclosed a decreased stake in Red Violet Inc by 0.2%.
This leaves the value of the investment at $23 billion and 904,914 shares.
The two most similar investment funds to Nantahala Capital Management are Montag A & Associates Inc and Ninety One North America. They manage $1.98 trillion and $1.98 trillion respectively.
Nantahala Capital Management’s portfolio is diversified across 8 sectors.
Currently, their heaviest sector is Health Care — making up 52.9% of
the total portfolio value.
The fund focuses on investments in the United States as
54.9% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
21% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $452 million.
These positions were updated on August 20th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Soleno Therapeutics Inc |
155.74%
6,164,214
|
$251,499,932,000 | 12.72% |
| Establishment Labs Holdings Inc |
155.82%
5,025,700
|
$228,367,808,000 | 11.55% |
| Peloton Interactive Inc |
246.44%
21,870,662
|
$73,922,838,000 | 3.74% |
| Evolus Inc |
100.00%
5,821,698
|
$63,165,424,000 | 3.19% |
| Bioventus Inc |
83.89%
10,676,628
|
$61,390,612,000 | 3.10% |
| Pathward Financial Inc |
5.98%
1,082,866
|
$61,257,730,000 | 3.10% |
| Imax Corp |
63.24%
3,596,520
|
$60,313,640,000 | 3.05% |
| Hilton Grand Vacations Inc |
100.00%
1,337,742
|
$54,084,910,000 | 2.73% |
| Savara Inc |
496.40%
10,361,902
|
$41,758,466,000 | 2.11% |
| Americas Car Mart, Inc. |
100.00%
624,256
|
$37,586,454,000 | 1.90% |
| RumbleON Inc |
100.00%
8,833,012
|
$36,215,350,000 | 1.83% |
| Keros Therapeutics, Inc. |
157.69%
757,614
|
$34,622,960,000 | 1.75% |
| Amneal Pharmaceuticals Inc |
103.82%
5,339,886
|
$33,908,276,000 | 1.71% |
| Abeona Therapeutics Inc |
200.35%
6,940,074
|
$29,425,912,000 | 1.49% |
| OptiNose Inc |
984.65%
26,837,480
|
$28,850,292,000 | 1.46% |
| Abivax Sa |
95.17%
1,971,268
|
$26,060,162,000 | 1.32% |
| Rezolute Inc |
97.82%
5,979,926
|
$25,713,682,000 | 1.30% |
| Bancorp Inc. (The) |
Opened
675,692
|
$25,514,130,000 | 1.29% |
| Reservoir Media Inc |
100.00%
3,101,594
|
$24,502,592,000 | 1.24% |
| Uniqure Nv |
71.66%
5,300,944
|
$23,748,230,000 | 1.20% |
| Zevra Therapeutics Inc |
97.23%
4,838,870
|
$23,710,464,000 | 1.20% |
| Assertio Holdings, Inc. |
100.00%
18,541,672
|
$22,991,674,000 | 1.16% |
| TELA Bio, Inc. |
345.53%
4,891,334
|
$22,989,270,000 | 1.16% |
| Red Violet Inc |
18.93%
904,914
|
$22,984,816,000 | 1.16% |
| Codexis Inc. |
62.69%
7,259,244
|
$22,503,656,000 | 1.14% |
| Eagle Pharmaceuticals Inc |
211.75%
3,924,140
|
$21,975,184,000 | 1.11% |
| Payoneer Global Inc |
113.87%
3,895,522
|
$21,581,191,000 | 1.09% |
| Aura Biosciences Inc |
92.16%
2,540,070
|
$19,202,930,000 | 0.97% |
| Viemed Healthcare Inc |
85.16%
2,870,244
|
$18,800,098,000 | 0.95% |
| Syndax Pharmaceuticals Inc |
94.83%
906,464
|
$18,609,706,000 | 0.94% |
| Immatics N.v |
100.00%
1,575,948
|
$18,312,516,000 | 0.93% |
| Tourmaline Bio Inc |
100.00%
1,401,814
|
$18,027,328,000 | 0.91% |
| Vanda Pharmaceuticals Inc |
214.54%
3,187,032
|
$18,006,730,000 | 0.91% |
| Elutia Inc |
117.66%
3,591,394
|
$17,813,314,000 | 0.90% |
| Lyra Therapeutics, Inc. |
Closed
2,820,982
|
$17,546,508,000 | |
| eHealth Inc |
100.00%
3,823,642
|
$17,321,098,000 | 0.88% |
| Eventbrite Inc |
Opened
3,200,000
|
$15,488,000,000 | 0.78% |
| Luxfer Hldgs Plc |
76.33%
1,208,286
|
$14,004,034,000 | 0.71% |
| Industrial Logistics Pptys T |
98.81%
3,739,906
|
$13,762,854,000 | 0.70% |
| Ocular Therapeutix Inc |
Opened
2,000,000
|
$13,680,000,000 | 0.69% |
| Noodles & Company |
113.64%
8,616,658
|
$13,614,320,000 | 0.69% |
| RMR Group Inc (The) |
73.97%
601,584
|
$13,595,798,000 | 0.69% |
| Disc Medicine Inc |
Opened
300,000
|
$13,521,000,000 | 0.68% |
| Alta Equipment Group Inc |
316.50%
1,676,444
|
$13,478,610,000 | 0.68% |
| Cogent Biosciences, Inc. |
100.00%
1,581,872
|
$13,335,180,000 | 0.67% |
| Mineralys Therapeutics Inc |
220.30%
1,065,012
|
$12,460,640,000 | 0.63% |
| Dyne Therapeutics, Inc. |
Closed
435,256
|
$12,356,918,000 | |
| Astria Therapeutics Inc |
Opened
1,350,000
|
$12,285,000,000 | 0.62% |
| Vistagen Therapeutics Inc. |
100.00%
3,035,392
|
$10,563,164,000 | 0.53% |
| The One Group Hospitality In |
339.11%
2,405,056
|
$10,221,488,000 | 0.52% |
| Nektar Therapeutics |
231.99%
8,220,000
|
$10,192,800,000 | 0.52% |
| InspireMD Inc |
96.14%
4,053,200
|
$10,113,950,000 | 0.51% |
| Golden Entmt Inc |
Closed
269,267
|
$9,917,104,000 | |
| Avadel Pharmaceuticals plc |
Opened
700,000
|
$9,842,000,000 | 0.50% |
| DXP Enterprises, Inc. |
23.50%
206,412
|
$9,461,926,000 | 0.48% |
| Neuropace Inc |
58.51%
1,233,646
|
$9,326,364,000 | 0.47% |
| Reading International Inc |
91.69%
6,489,146
|
$9,214,588,000 | 0.47% |
| Cellectar Biosciences Inc |
95.73%
3,666,650
|
$9,166,624,000 | 0.46% |
| Zynex Inc |
100.00%
980,000
|
$9,133,600,000 | 0.46% |
| NN Inc |
107.11%
2,912,892
|
$8,738,676,000 | 0.44% |
| DHI Group Inc |
110.17%
4,132,834
|
$8,637,624,000 | 0.44% |
| Centessa Pharmaceuticals Plc |
Opened
900,000
|
$8,127,000,000 | 0.41% |
| Gaia Inc |
100.00%
1,830,058
|
$8,070,556,000 | 0.41% |
| Context Therapeutics Inc |
Opened
3,870,968
|
$7,761,290,000 | 0.39% |
| Lexicon Pharmaceuticals Inc |
Opened
4,608,300
|
$7,741,944,000 | 0.39% |
| Silence Therapeutics plc |
100.00%
400,000
|
$7,600,000,000 | 0.38% |
| Theratechnologies Inc. |
100.00%
5,364,456
|
$7,510,238,000 | 0.38% |
| Enova International Inc. |
55.84%
111,998
|
$6,971,876,000 | 0.35% |
| Perella Weinberg Partners |
301.34%
400,449
|
$6,507,297,000 | 0.33% |
| Aytu BioPharma Inc |
100.00%
2,173,624
|
$6,346,982,000 | 0.32% |
| Brightcove Inc |
Opened
2,627,536
|
$6,227,260,000 | 0.31% |
| Eton Pharmaceuticals, Inc. |
Opened
1,881,466
|
$6,190,024,000 | 0.31% |
| Achieve Life Sciences Inc. |
100.00%
1,308,000
|
$6,147,600,000 | 0.31% |
| Benitec Biopharma Inc |
Opened
841,395
|
$5,881,351,000 | 0.30% |
| DarioHealth Corp |
81.67%
4,782,650
|
$5,691,354,000 | 0.29% |
| Tarsus Pharmaceuticals, Inc. |
Closed
150,321
|
$5,464,168,000 | |
| Fossil Group Inc |
191.70%
3,810,556
|
$5,391,936,000 | 0.27% |
| Neurogene Inc |
100.00%
144,558
|
$5,260,466,000 | 0.27% |
| PlayAGS Inc |
Closed
566,588
|
$5,087,960,000 | |
| Envveno Medical Corporation |
92.79%
955,710
|
$5,017,478,000 | 0.25% |
| Milestone Pharmaceuticals In |
100.00%
3,500,000
|
$4,620,000,000 | 0.23% |
| Xtant Med Hldgs Inc |
79.00%
7,160,000
|
$4,510,800,000 | 0.23% |
| Conns Inc |
122.97%
3,946,630
|
$4,361,026,000 | 0.22% |
| Spdr Ser Tr |
6.34%
44,738
|
$4,147,660,000 | 0.21% |
| Newamsterdam Pharma Company |
Closed
175,000
|
$4,138,750,000 | |
| Surrozen Inc |
Opened
374,412
|
$4,099,812,000 | 0.21% |
| Talphera Inc |
100.00%
3,985,038
|
$3,546,684,000 | 0.18% |
| Scully Royalty Ltd |
100.00%
478,394
|
$3,406,166,000 | 0.17% |
| MediaAlpha, Inc. |
65.45%
247,128
|
$3,254,676,000 | 0.16% |
| Spar Group, Inc. |
50.60%
1,324,056
|
$3,190,974,000 | 0.16% |
| Eledon Pharmaceuticals, Inc. |
Opened
1,200,000
|
$3,168,000,000 | 0.16% |
| Altisource Portfolio Solns S |
100.00%
2,182,018
|
$3,076,646,000 | 0.16% |
| Unicycive Therapeutics Inc |
69.11%
5,640,716
|
$2,826,564,000 | 0.14% |
| Anebulo Pharmaceuticals Inc |
100.00%
1,022,146
|
$2,790,458,000 | 0.14% |
| Aerovate Therapeutics Inc |
Closed
91,188
|
$2,696,429,000 | |
| Instil Bio Inc |
100.00%
254,584
|
$2,619,670,000 | 0.13% |
| Aileron Therapeutics Inc |
264.21%
928,734
|
$2,572,594,000 | 0.13% |
| Lazydays Holdings Inc |
Opened
1,000,000
|
$2,540,000,000 | 0.13% |
| Verastem Inc |
Opened
800,000
|
$2,384,000,000 | 0.12% |
| STRATA Skin Sciences Inc |
Opened
607,834
|
$1,866,050,000 | 0.09% |
| Perfect Corp |
319.13%
838,266
|
$1,693,298,000 | 0.09% |
| Reneo Pharmaceuticals Inc |
Opened
1,095,608
|
$1,692,714,000 | 0.09% |
| Aprea Therapeutics, Inc. |
100.00%
411,520
|
$1,674,886,000 | 0.08% |
| Nikola Corporation |
Opened
199,998
|
$1,637,984,000 | 0.08% |
| Neuroone Med Technologies Co |
58.64%
1,901,924
|
$1,521,540,000 | 0.08% |
| Kiora Pharmaceuticals Inc |
Closed
1,900,000
|
$1,341,400,000 | |
| Gossamer Bio, Inc. |
100.00%
1,345,712
|
$1,246,130,000 | 0.06% |
| Matterport Inc |
Closed
548,376
|
$1,239,330,000 | |
| STRATA Skin Sciences Inc |
Closed
3,089,821
|
$1,167,952,000 | |
| Childrens Pl Inc New |
Closed
100,000
|
$1,154,000,000 | |
| Kiora Pharmaceuticals Inc |
Opened
211,110
|
$886,662,000 | 0.04% |
| B. Riley Financial Inc |
23.30%
47,952
|
$845,874,000 | 0.04% |
| Evoke Pharma Inc |
100.00%
1,350,000
|
$714,150,000 | 0.04% |
| Ishares Tr |
Opened
3,032
|
$615,162,000 | 0.03% |
| Ladder Cap Corp |
100.00%
51,262
|
$578,748,000 | 0.03% |
| Fortress Biotech Inc |
10.12%
306,304
|
$523,780,000 | 0.03% |
| Edgewise Therapeutics Inc |
100.00%
26,742
|
$481,624,000 | 0.02% |
| An2 Therapeutics Inc |
100.00%
196,556
|
$422,596,000 | 0.02% |
| Bm Technologies Inc |
100.00%
152,068
|
$342,152,000 | 0.02% |
| Exagen Inc |
59.65%
118,632
|
$215,910,000 | 0.01% |
| Lucid Diagnostics Inc |
68.82%
252,724
|
$207,234,000 | 0.01% |
| Transact Technologies Inc. |
68.18%
40,246
|
$151,728,000 | 0.01% |
| Aptose Biosciences Inc |
74.70%
154,680
|
$117,402,000 | 0.01% |
| Renalytix Plc |
100.00%
235,288
|
$54,352,000 | 0.00% |
| Cue Biopharma Inc |
Closed
26,692
|
$50,448,000 | |
| Gamida Cell Ltd |
Closed
800,000
|
$28,880,000 | |
| Kintara Therapeutics, Inc. |
Closed
12,763
|
$1,285,000 | |
| Arhaus Inc |
Closed
1
|
$15,000 | |
| No transactions found | |||
| Showing first 500 out of 128 holdings | |||